2.77
price up icon10.57%   0.31
 
loading
Celularity Inc stock is traded at $2.77, with a volume of 496.77K. It is up +10.57% in the last 24 hours and up +8.37% over the past month. Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
See More
Previous Close:
$2.46
Open:
$2.34
24h Volume:
496.77K
Relative Volume:
0.51
Market Cap:
$57.16M
Revenue:
$14.79M
Net Income/Loss:
$-181.41M
P/E Ratio:
-5.6531
EPS:
-0.49
Net Cash Flow:
$-68.18M
1W Performance:
-20.47%
1M Performance:
+8.37%
6M Performance:
-9.33%
1Y Performance:
+29.65%
1-Day Range:
Value
$2.28
$2.95
1-Week Range:
Value
$2.1183
$4.3379
52-Week Range:
Value
$1.30
$7.97

Celularity Inc Stock (CELU) Company Profile

Name
Name
Celularity Inc
Name
Phone
(908) 768-2170
Name
Address
170 PARK AVE, FLORHAM PARK
Name
Employee
120
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
CELU's Discussions on Twitter

Compare CELU with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
CELU 2.77 57.16M 14.79M -181.41M -68.18M -0.49
VRTX 467.17 119.83B 10.63B -479.80M -1.35B 13.33
REGN 760.91 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 566.22 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.39 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.55 24.08B 3.30B -501.07M 1.03B 11.54

Celularity Inc Stock (CELU) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-30-23 Downgrade Morgan Stanley Equal-Weight → Underweight
Dec-22-22 Downgrade Oppenheimer Outperform → Perform
Jun-22-22 Initiated H.C. Wainwright Buy
Apr-06-22 Downgrade Truist Buy → Hold
Jan-28-22 Initiated Oppenheimer Outperform
Nov-24-21 Initiated Morgan Stanley Equal-Weight
View All

Celularity Inc Stock (CELU) Latest News

pulisher
08:44 AM

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter - The Manila Times

08:44 AM
pulisher
08:30 AM

Celularity Resolves Nasdaq Compliance Issue, Maintains Listing After Filing Reports | CELU Stock News - StockTitan

08:30 AM
pulisher
Nov 17, 2024

Celularity Inc. (NASDAQ:CELU) Sees Significant Increase in Short Interest - MarketBeat

Nov 17, 2024
pulisher
Nov 11, 2024

After-Market Momentum: Celularity (CELU) Shares Climb On Increased Guidance - Stocks Telegraph

Nov 11, 2024
pulisher
Nov 09, 2024

Celularity sets annual meeting date, stockholder proposal deadline By Investing.com - Investing.com Canada

Nov 09, 2024
pulisher
Nov 08, 2024

Celularity sets annual meeting date, stockholder proposal deadline - Investing.com India

Nov 08, 2024
pulisher
Nov 07, 2024

Celularity Inc. (CELU) Quarterly 10-Q Report - Quartzy

Nov 07, 2024
pulisher
Nov 07, 2024

Celularity Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

U.S. Stock market: Celularity(+52.68%), Applovin(+45.14%), FARO Technologies(+33.01%) and others were among the top gainers during mid day trading - Business Upturn

Nov 07, 2024
pulisher
Nov 07, 2024

Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Celularity Raises 2024 Sales Forecast to $60M After Record-Breaking October Revenue | CELU Stock News - StockTitan

Nov 07, 2024
pulisher
Oct 31, 2024

CELU stock touches 52-week low at $1.55 amid market fluctuations - Investing.com India

Oct 31, 2024
pulisher
Oct 30, 2024

CELU stock touches 52-week low at $1.55 amid market fluctuations By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 26, 2024

Celularity reports over $24 million in biomaterial revenue By Investing.com - Investing.com Australia

Oct 26, 2024
pulisher
Oct 26, 2024

Celularity Inc. Announces Anticipated Revenues for Second and Third Quarters - Defense World

Oct 26, 2024
pulisher
Oct 25, 2024

Celularity reports over $24 million in biomaterial revenue - Investing.com India

Oct 25, 2024
pulisher
Oct 25, 2024

Celularity Receives Nasdaq Delisting Notice Over Filing Delay - Marketscreener.com

Oct 25, 2024
pulisher
Oct 23, 2024

Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel - The Manila Times

Oct 23, 2024
pulisher
Oct 23, 2024

Celularity reports progress on Nasdaq compliance and product sales - Investing.com

Oct 23, 2024
pulisher
Oct 22, 2024

Celularity reports progress on Nasdaq compliance and product sales By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 22, 2024

Celularity Provides Corporate Update - citybiz

Oct 22, 2024
pulisher
Oct 22, 2024

CELUWCelularity Inc. Warrant Latest Stock News & Market Updates - StockTitan

Oct 22, 2024
pulisher
Oct 22, 2024

Celularity to submit 510(k) notification for Tendon Wrap in early 2025 - TipRanks

Oct 22, 2024
pulisher
Oct 21, 2024

Celularity faces Nasdaq delisting over reporting delays - Investing.com

Oct 21, 2024
pulisher
Oct 21, 2024

Celularity faces Nasdaq delisting over reporting delays By Investing.com - Investing.com UK

Oct 21, 2024
pulisher
Oct 18, 2024

Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal - ForexTV.com

Oct 18, 2024
pulisher
Oct 17, 2024

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc. - The Manila Times

Oct 17, 2024
pulisher
Oct 16, 2024

Celularity expands biomaterials range with Rebound acquisition - Investing.com India

Oct 16, 2024
pulisher
Oct 16, 2024

Celularity Inc SEC 10-Q Report - TradingView

Oct 16, 2024
pulisher
Oct 08, 2024

Stem Cell Umbilical Cord Blood Market Report 2024, with Profiles of Cryo-Cell, Cordlife, ViaCord, CryoHoldco, LifeCell, StemCyte, Celularity Cryo-Save and Vita 34 - Yahoo Finance

Oct 08, 2024
pulisher
Oct 03, 2024

Celularity (NASDAQ:CELU) Stock Price Down 8.8%Should You Sell? - MarketBeat

Oct 03, 2024
pulisher
Sep 19, 2024

Amniotic Membrane Market to Grow by USD 2.7 Billion (2024-2028) with AI Impact Boosting Trends in Ophthalmic Surgery UseTechnavio Report - The Malaysian Reserve

Sep 19, 2024
pulisher
Sep 18, 2024

BTIG maintains Buy rating on Cullinan Oncology stock - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

Cullinan Oncology maintains Buy rating from H.C. Wainwright with steady price target - Investing.com India

Sep 18, 2024
pulisher
Sep 18, 2024

Trend Tracker for (CLS) - Stock Traders Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Cullinan Therapeutics (NASDAQ:CGEM) Earns Outperform Rating from Wedbush - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

Caesars Entertainment Inc (CZR) stock: A year of ups and downs - US Post News

Sep 18, 2024
pulisher
Sep 18, 2024

In the Green: Cerus Corp. (CERS) Closes at 1.97, Up/Down -4.37 from Previous Day - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Creo Medical to get £25m boost from majority sale of its European business - Business Live

Sep 18, 2024
pulisher
Sep 18, 2024

Medical device company to sell stake of subsidiary to Chinese manufacturerequity value of €72m - Insider Media

Sep 18, 2024
pulisher
Sep 18, 2024

Objective long/short (CGEM) Report - Stock Traders Daily

Sep 18, 2024
pulisher
Sep 18, 2024

CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA - Yahoo Finance

Sep 18, 2024
pulisher
Sep 18, 2024

Cullinan Therapeutics Inc (CGEM)’s stock price in review: A technical analysis - US Post News

Sep 18, 2024
pulisher
Sep 18, 2024

(CELC) Technical Pivots with Risk Controls - Stock Traders Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Creo Medical Partners with Micro-Tech for Strategic Growth - TipRanks

Sep 18, 2024
pulisher
Sep 18, 2024

E Fund Management Co. Ltd. Purchases New Shares in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

State of New Jersey Common Pension Fund D Has $3.31 Million Stock Holdings in Caesars Entertainment, Inc. (NASDAQ:CZR) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Cellectis (NASDAQ:CLLS) Coverage Initiated at StockNews.com - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

Cullinan Therapeutics commences Phase 1 trial for lupus treatment By Investing.com - Investing.com Canada

Sep 18, 2024
pulisher
Sep 17, 2024

Celcuity Inc. (NASDAQ:CELC) Short Interest Update - MarketBeat

Sep 17, 2024

Celularity Inc Stock (CELU) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.25
price down icon 0.96%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):